Drug Profile
Research programme: anti-fibrotic therapeutics - Connexios
Alternative Names: CNX-014; CNX-023; CNX-024; CNX-025Latest Information Update: 28 Nov 2019
Price :
$50
*
At a glance
- Originator Connexios Life Sciences
- Class
- Mechanism of Action G protein-coupled receptor modulators; Mitogen-activated protein kinase modulators; Peptide hydrolase modulators; Protein kinase modulators; Protein tyrosine kinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Fibrosis
Most Recent Events
- 28 Nov 2019 No recent reports of development identified for research development in Fibrosis in India
- 15 Oct 2015 Early research in Fibrosis in India before October 2015 (unspecified route)